VERTEX PHARMACEUTICALS INC (VRTX)
US92532F1003 - Common Stock
ChartMill assigns a Buy % Consensus number of 77% to VRTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 529.12. This target is 33.19% above the current price.
VRTX was analyzed by 41 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about VRTX.
In the previous month the buy percentage consensus was at a similar level.
VRTX was analyzed by 41 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-20 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-12-20 | Needham | Reiterate | Hold -> Hold |
| 2024-12-20 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-12-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-19 | B of A Securities | Maintains | Buy -> Buy |
| 2024-12-16 | Stifel | Maintains | Hold -> Hold |
| 2024-12-09 | Jefferies | Upgrade | Hold -> Buy |
| 2024-11-14 | Citigroup | Initiate | Buy |
| 2024-11-06 | Canaccord Genuity | Maintains | Sell -> Sell |
| 2024-11-05 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-05 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2024-11-05 | UBS | Maintains | Buy -> Buy |
| 2024-11-05 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-11-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-11-05 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-30 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-17 | UBS | Maintains | Buy -> Buy |
| 2024-10-16 | ScotiaBank | Initiate | Sector Perform |
| 2024-10-14 | B of A Securities | Maintains | Buy -> Buy |
| 2024-10-10 | Raymond James | Reiterate | Market Perform |
| 2024-10-09 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-10-08 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-10-04 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-10-01 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-09-19 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-08-05 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-05 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2024-08-05 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-08-05 | JP Morgan | Maintains | Overweight -> Overweight |